High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial

J. N. Hoes, J. W. G. Jacobs, H. M. J. Hulsmans, R. N. J. T. L. de Nijs, Willem F. Lems, G. A. W. Bruyn, P. P. M. M. Geusens, Johannes W J Bijlsma

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)354-359
JournalClinical and Experimental Rheumatology
Volume28
Issue number3
Publication statusPublished - 2010

Keywords

  • Glucocorticoid induced osteoporosis
  • bisphosphonate
  • vitamin D
  • alendronate
  • alfacalcidol
  • rheumatic disease
  • vertebral fracture
  • STOP-trial

Cite this